About the Eurasian Pharmaceutical Registry

The Eurasian Pharmaceutical Registry (Eurasian Pharmaceutical Registry) started its work on March 1, 2021 and is an open public information resource.

The purpose of the Eurasian Pharmaceutical Register is to inform interested parties about the existence of exclusive rights to protected inventions related to pharmacologically active substances, their combinations, methods of their preparation and medical use in the territory of the Eurasian space. For this purpose, information on Eurasian patents valid in the territory of the member states of the Eurasian Patent Organization (EAPO), as well as on national patents of the member states of the Eurasian Patent Convention (EAPC) is included into the register.

It is also contains up-to-date information on the legal status of these patents, on license agreements concluded and on medicines registered in these states. As a result, the Eurasian Pharmaceutical Register provides patent holders with additional opportunities to protect their rights and is an accessible source of reliable and up-to-date information for a wide range of stakeholders (from developers of pharmaceutical active substances to those involved in the registration of medicines and their introduction into civil circulation).

The functioning of the Eurasian Pharmaceutical Register is regulated by the Regulation on the Eurasian Pharmaceutical Register. According to this document, at present the Eurasian Patent Office (EAPO) enters information into the Eurasian Pharmaceutical Register both at the request of patent holders and proactively in respect of Eurasian patents for which there are registered medicines in the territories of the EAPC member states.

Regulation on the Eurasian Pharmaceutical Register provides for the possibility of recognizing the information included in it as official for the purpose of certifying the fact of protection in the territory of a Contracting State of pharmacologically active substances, methods of their production and their medical use, protected by Eurasian and (or) national patents for use in such a Contracting State. It also provides for the possibility of making changes and additions to the Eurasian Pharmaceutical Register, including the exclusion of information from it. In addition, any person may obtain an extract from the Eurasian Pharmaceutical Register, subject to payment for this service at a tariff established by the EAPO. Such extract contains information on the compliance of the patented subject matter with a specific international nonproprietary name (INN) or combination of INN with the indication of claims under the Eurasian or national patent, respectively, protecting the pharmacologically active substance.

EAPO Pharm Registry can be accessed by clicking here.

More news about intellectual property in our social networks (Facebook, Instagram, Telegram).